- Home
- MSGS vs HIMS Comparison
MSGS vs HIMS Comparison
Compare MSGS & HIMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MSGS | HIMS |
|---|---|---|
| Founded | 1879 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Services-Misc. Amusement & Recreation | Medical/Nursing Services |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.2B | 6.6B |
| IPO Year | 2015 | 2019 |
Fundamental Metrics
Financial Performance| Metric | MSGS | HIMS |
|---|---|---|
| Price | $332.76 | $29.84 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 9 | 14 |
| Target Price | ★ $326.29 | $29.50 |
| AVG Volume (30 Days) | 182.0K | ★ 26.4M |
| Earning Date | 05-04-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 0.51 |
| Revenue | N/A | ★ $2,347,637,000.00 |
| Revenue This Year | N/A | $19.82 |
| Revenue Next Year | $4.52 | $19.23 |
| P/E Ratio | ★ N/A | $61.20 |
| Revenue Growth | N/A | ★ 59.00 |
| 52 Week Low | $184.63 | $13.74 |
| 52 Week High | $345.48 | $70.43 |
Technical Indicators
Market Signals| Indicator | MSGS | HIMS |
|---|---|---|
| Relative Strength Index (RSI) | 57.91 | 69.94 |
| Support Level | $303.92 | $28.94 |
| Resistance Level | $335.08 | $36.45 |
| Average True Range (ATR) | 8.53 | 1.92 |
| MACD | 0.38 | 1.22 |
| Stochastic Oscillator | 58.02 | 84.58 |
Price Performance
Historical ComparisonAbout MSGS Madison Square Garden Sports Corp. (New)
Madison Square Garden Sports Corp owns and operates a portfolio of assets featuring some of the recognized sports teams, including the Knicks of the NBA and the Rangers of the NHL. It generates revenue from several sources: ticket sales and a portion of suite rental fees at The Garden and others. It has one operating and reportable segment and one reporting unit for goodwill impairment testing purposes.
About HIMS Hims & Hers Health Inc.
Hims & Hers, launched in 2017, is a telehealth platform that connects patients and healthcare providers to offer treatment options for specialties like erectile dysfunction, hair loss, skin care, mental health, and weight loss. Its offerings include generic, branded, and compounded prescription drugs as well as over-the-counter medicines, cosmetics, and supplements. The platform, which has more than 2 million subscribers, is available in all 50 states and certain European markets like the UK. It includes provider networks, electronic medical records, cloud pharmacy fulfillment, and personalization capabilities. Hims does not take insurance and only accepts payments directly from customers.